Evidence map›Paper›PMID 37733111›Full record

ArticleJournal of fluorescence2024

Design and Synthesis of Novel Fluorescent 2-(aryloxy)-3-(4,5-diaryl)-1H-imidazol-2-yl)quinolines: Solvatochromic, DFT, TD-DFT Studies, COX-1 and COX-2 Inhibition and Antioxidant Properties.

Lokesh Bheemayya, Ravindra R Kamble, Arun K Shettar, Tukaram V Metre, Barnabas Kodasi, Madivalagouda S Sannaikar, Sanjeev R Inamdar, Mussuvir Pasha K M, Joy H Hoskeri

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of fluorescence, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lokesh BheemayyaDepartment of Chemistry, Karnatak University, Dharwad, 580003, India.
Ravindra R KambleDepartment of Chemistry, Karnatak University, Dharwad, 580003, India. ravichem@kud.ac.in.
Arun K ShettarDepartment of Preclinical Research and Drug Development, Cytxon Biosolutions Pvt Ltd, Hubli, 580031, India.
Tukaram V MetreDepartment of Chemistry, Karnatak University, Dharwad, 580003, India.
Barnabas KodasiDepartment of Chemistry, Karnatak University, Dharwad, 580003, India.
Madivalagouda S SannaikarDepartment of Studies in Physics, Karnatak University, Dharwad, 580003, India.
Sanjeev R InamdarDepartment of Studies in Physics, Karnatak University, Dharwad, 580003, India.
Mussuvir Pasha K MDepartment of Chemistry, Karnatak Science College, Dharwad, 580 003, India.
Joy H HoskeriDepartment of Bioinformatics and Biotechnology, Karnataka State Akkamahadevi Women's University, Vijayapura, 586108, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present work focuses on the synthesis of novel heterocycles 2-(aryloxy)-3-(4,5-diaryl-1H-imidazol-2-yl)quinolines (6k-v) by an effective condensation reaction. These molecules exhibited fluorescent properties and hence for the proper understanding of their optical behavior and quantum yields, solvatochromic studies have been carried out. Further, frontier molecular orbitals, molecular electrostatic potential (MEP), and geometrical structure optimization have been investigated using the B

Indexed as

Anti-inflammatory activityAntioxidant activityDFTImidazoleQuinolineSolvatochromicTD-DFT

Identifiers

PMID37733111

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.